Controverse legate de publicitatea unui medicament neaprobat de autorități.
Recent developments in the unregulated pharmaceuticals market have surfaced through a curious promotional video featuring Ofer Barkan, a media personality. In the video, Barkan showcases a product called „Snafurus,” supposedly a potent alternative to Viagra and Kamagra, boasting a double dosage at 200 mg. The commercial quickly raises red flags: Barkan appears both disheveled and desperate, imploring viewers to buy this „miracle pill” – a message that raises significant ethical and health concerns.
The ad suggests that Snafurus can be acquired without prescription, misleadingly claimed to have health ministry approval. However, inquiries to the company revealed vague responses and refusal to disclose the manufacturer. Notably, health authorities clarified that Viagra and its counterparts require medical prescriptions and that Snafurus’ purported dosage exceeds approved limits, further highlighting potential dangers.
In June 2023, Israel’s health ministry had previously warned about counterfeit medications, including Snafurus, which were confiscated from illegal production facilities. These medications are not subject to safety checks, creating a dangerous situation. Dr. Roni Berkowitz, head of enforcement at the health ministry, emphasized that unregulated pills could lead to serious health risks or even fatal outcomes.
Even in the face of these serious allegations, Barkan deflected responsibility, claiming he’s merely the spokesperson and reiterated, “I just said what I was told.” This emphasizes a troubling trend in advertising, where the allure of profit can overshadow the potential hazards to consumers’ health.
In light of this situation, what steps are being taken to regulate such deceptive practices in pharmaceutical advertising? The health ministry has initiated communication with law enforcement to address illegal sales of medications and is urging the public to obtain medicines only from licensed pharmacies.
Ce implică această situație pentru consumatori?
Este o amenințare directă la sănătatea publicului, subliniind riscurile achiziției de medicamente din surse necontrolate și promovarea frauduloasă.
Care sunt consecințele posibile ale activităților lui Barkan?
Acțiunile sale pot destabiliza încrederea în sistemul de sănătate și pot conduce la posibile studii sau reglementări stricte asupra publicității farmaceutice.
Cum pot consumatorii să se protejeze în fața unor produse nesigure?
Este esențial să achiziționeze medicamente doar din locuri autorizate și să se sfătuiască cu profesioniști din domeniul sănătății înainte de a lua orice produs nou.
Sursa: •haaretz•
